Proprietary AI analyst is now available
- Public Comps
- Accrelist
Accrelist Valuation Multiples
Discover Accrelist's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Ecomiam, Bergholm, Labo Euromedis, DM-KER and more.
Accrelist Overview
About Accrelist
Accrelist Ltd is focused on the distribution of electronics components, plastic injection molding, mold design, and fabrication services. The company's segment comprises a Mechanical business unit (MBU), Aesthetic Medical Services (AMS), and others. Accrelist is focused on maintaining a diversified customer mix and product portfolio for MBU and EBU while continuing to expand upon the medical aesthetic products and services provided to consumers. it generates a vast majority of revenue from the MBU segment.
Founded
1986
HQ

Employees
671
Website
Sectors
Financials (FY)
EV
$16M
Valuation Multiples
Start free trialAccrelist Financials
Accrelist reported last fiscal year revenue of $12M and EBITDA of $1M.
In the same fiscal year, Accrelist generated $6M in gross profit, $1M in EBITDA, and had net loss of ($204K).
Accrelist P&L
In the most recent fiscal year, Accrelist reported revenue of $12M and EBITDA of $1M.
Accrelist is unprofitable as of last fiscal year, with gross margin of 47%, EBITDA margin of 8%, and net margin of (2%).
Financial data powered by Morningstar, Inc.
Accrelist Stock Performance
Accrelist has current market cap of $15M, and enterprise value of $16M.
Market Cap Evolution
Accrelist's stock price is $0.05.
Accrelist share price increased by 9.4% in the last 30 days.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16M | $15M | -0.1% | 9.4% | - | - | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAccrelist Valuation Multiples
Accrelist trades at 1.3x EV/Revenue multiple, and 15.5x EV/EBITDA.
Accrelist Financial Valuation Multiples
As of June 24, 2026, Accrelist has market cap of $15M and EV of $16M.
Accrelist has a P/E ratio of (74.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Accrelist Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Accrelist Margins & Growth Rates
In the most recent fiscal year, Accrelist reported gross margin of 47%, EBITDA margin of 8%, and net margin of (2%).
Accrelist Margins
Accrelist Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Accrelist Operational KPIs
Accrelist's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Accrelist's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Accrelist's Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Accrelist Competitors
Accrelist competitors include Ecomiam, Bergholm, Labo Euromedis, DM-KER, KDA Group, Innelec Multimedia, Fountain, Longino & Cardenal, Sipex and High Quality Food.
Most Accrelist public comparables operate across Wholesale Distribution.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | 0.3x | (5.2x) | (8.9x) | |||
| 0.2x | - | 5.1x | - | |||
| 0.2x | - | 9.6x | - | |||
| 1.5x | - | 10.8x | - | |||
| 92.1x | - | (2.6x) | - | |||
| 0.2x | 0.2x | (27.9x) | 18.3x | |||
| 0.4x | - | 4.1x | - | |||
| 0.3x | 0.3x | 14.0x | 7.8x | |||
This data is available for Pro users. Sign up to see all Accrelist competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Accrelist
Accrelist has acquired 1 company to date.
Last acquisition by Accrelist was on April 18th 2023. Accrelist acquired SJY Medical for $800K (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Accrelist
| Description | - |
| HQ Country | |
| HQ City | Singapore |
| Deal Date | 18 Apr 2023 |
| Valuation | $800K |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Accrelist acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Accrelist
| When was Accrelist founded? | Accrelist was founded in 1986. |
| Where is Accrelist headquartered? | Accrelist is headquartered in Singapore. |
| How many employees does Accrelist have? | As of today, Accrelist has over 671 employees. |
| Is Accrelist publicly listed? | Yes, Accrelist is a public company listed on Singapore Exchange. |
| What is the stock symbol of Accrelist? | Accrelist trades under QZG ticker. |
| When did Accrelist go public? | Accrelist went public in 2002. |
| Who are competitors of Accrelist? | Accrelist main competitors include Ecomiam, Bergholm, Labo Euromedis, DM-KER, KDA Group, Innelec Multimedia, Fountain, Longino & Cardenal, Sipex, High Quality Food. |
| What is the current market cap of Accrelist? | Accrelist's current market cap is $15M. |
| What is the current revenue of Accrelist? | Accrelist's last fiscal year revenue is $12M. |
| What is the current EV/Revenue multiple of Accrelist? | Current revenue multiple of Accrelist is 1.3x. |
| Is Accrelist profitable? | No, Accrelist is not profitable. |
| How many companies Accrelist has acquired to date? | As of June 2026, Accrelist has acquired 1 company. |
| What was the largest acquisition by Accrelist? | $800K acquisition of SJY Medical on 18th April 2023 was the largest M&A Accrelist has done to date. |
| What companies Accrelist acquired? | Accrelist acquired SJY Medical. |
| In how many companies Accrelist has invested to date? | Accrelist hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Accrelist
Lists including Accrelist
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
